Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Actinic Keratosis (AK)”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Not applicableLooking for participantsNCT07789002
What this trial is testing

Multimodal Laser Treatment of Photodamaged Skin

Who this might be right for
Photo-damageActinic Keratosis (AK)
Merete Haedersdal 35
Testing effectiveness (Phase 2)Study completedNCT03110159
What this trial is testing

DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients

Who this might be right for
Skin CancerNon-melanoma Skin CancerSun Damaged Skin+1 more
Medical Dermatology Specialists 8
Post-approval studies (Phase 4)UnknownNCT01656226
What this trial is testing

Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic Keratosis

Who this might be right for
Actinic Keratosis
ISDIN 50
Large-scale testing (Phase 3)Study completedNCT02124733
What this trial is testing

Protocols for Painless Photodynamic Therapy (PDT) of Actinic Keratoses

Who this might be right for
Actinic Keratosis
The Cleveland Clinic 23
Testing effectiveness (Phase 2)Study completedNCT01757613
What this trial is testing

Study Whose Purpose is to Find an Optimal Dose for the Treatment With AK 3012 in Patients With Actinic Keratosis

Who this might be right for
Actinic Keratosis Olsen Grade I/II
Dolorgiet GmbH & Co. KG 150
Large-scale testing (Phase 3)Study completedNCT04085367
What this trial is testing

Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face

Who this might be right for
Actinic Keratoses
Galderma R&D 557
Large-scale testing (Phase 3)WithdrawnNCT03024060
What this trial is testing

Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

Who this might be right for
Actinic Keratosis
DUSA Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Looking for participantsNCT07137819
What this trial is testing

Phase 3 - Evaluation of Veregen® 10% Ointment as New Herbal Topical Treatment for Actinic Keratosis

Who this might be right for
Actinic Keratosis of Face and Scalp
Aresus Pharma GmbH 280
Testing effectiveness (Phase 2)Study completedNCT00021294
What this trial is testing

Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis

Who this might be right for
Non-melanomatous Skin CancerPrecancerous/Nonmalignant Condition
University of Arizona
Large-scale testing (Phase 3)Study completedNCT00308854
What this trial is testing

Photodynamic Therapy With PD P 506 A Compared With Placebo-PDT for the Treatment of AK

Who this might be right for
Actinic Keratosis
photonamic GmbH & Co. KG 107
Not applicableLooking for participantsNCT07335003
What this trial is testing

Study of the Photoprotection and Prevention of Actinic Damage With Anthelios Fluide 100 KA+ UVMune 400 in Patients With Multiple Actinic Keratoses

Who this might be right for
Actinic Keratosis (AK)
Cosmetique Active International 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT07340697
What this trial is testing

Evaluate RLS-1496 Topical Cream for Actinic Keratosis

Who this might be right for
Actinic Keratosis (AK)
Rubedo Life Sciences, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT00335179
What this trial is testing

Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream

Who this might be right for
Actinic Keratosis
Graceway Pharmaceuticals, LLC 17
Testing effectiveness (Phase 2)Study completedNCT01516515
What this trial is testing

Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis

Who this might be right for
Actinic Keratosis
G&E Herbal Biotechnology Co., LTD 86
Not applicableStudy completedNCT05260073
What this trial is testing

Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis

Who this might be right for
Keratosis, Actinic
Almirall, S.A. 300
Large-scale testing (Phase 3)Study completedNCT00987246
What this trial is testing

Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis

Who this might be right for
Actinic Keratosis
Almirall, S.A. 470
Very early researchLooking for participantsNCT07286318
What this trial is testing

Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

Who this might be right for
Skin CancerCutaneous Squamous Cell Carcinoma (CSCC)Actinic Keratosis (AK)+1 more
Marissa Lobl 20
Not applicableStudy completedNCT07290959
What this trial is testing

Indoor Daylight Photodynamic Therapy is an Effective, First-line Treatment for AK, But Its Feasibility is Limited by the Time Required for the Illumination (2 Hours). Our Objective Was to Evaluate the Efficacy of Idl-PDT With an Illumination Time of 1 Hour Versus 2 Hours in the Treatment of Scalp AK

Who this might be right for
Actinic Keratosis (AK)
San Salvatore Hospital of L'Aquila 55
Large-scale testing (Phase 3)Study completedNCT00308867
What this trial is testing

PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AK

Who this might be right for
Actinic Keratosis
photonamic GmbH & Co. KG 349
Early research (Phase 1)Study completedNCT00544258
What this trial is testing

Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005

Who this might be right for
Actinic Keratoses
Peplin 8
Next Page